Netherlands Greenlights Tesla's Self-Driving Tech in EU First

After a year and a half of careful testing, Dutch regulators just gave Tesla's Full Self-Driving technology the green light, marking a historic first for Europe.

The Netherlands' vehicle authority, RDW, officially approved Tesla's FSD Supervised system for use on Dutch roads. Tesla drivers in the country will soon receive the update, though they'll need to complete a tutorial and quiz before activating the feature.

This isn't just a win for Tesla. It's a potential turning point for road safety across Europe.

The RDW emphasized that properly used driver assistance systems make roads safer by supporting drivers in their tasks. The agency specifically noted that FSD Supervised's continuous monitoring of drivers makes it safer than other assistance systems on the market.

The timing makes sense given Tesla's European headquarters sits in Amsterdam. The Netherlands has often served as a testing ground for innovative transportation solutions, from extensive bike infrastructure to early electric vehicle adoption.

Drivers receiving the update will see clear reminders that the system doesn't make their vehicles autonomous. The technology requires active supervision, keeping humans firmly in the driver's seat while providing an extra layer of safety support.

The Ripple Effect

This approval could unlock doors across the entire European Union. When one EU country approves a technology after thorough testing, it often creates momentum for broader adoption throughout the bloc.

Other European nations can now look to the Netherlands' 18-month testing period as evidence of the system's viability. That extensive evaluation period demonstrates the serious approach regulators took in assessing safety before approval.

The advancement represents progress toward a future where technology and human drivers work together to reduce accidents. Every innovation in driver assistance brings us closer to roads where technology helps prevent the mistakes that cause crashes.

This milestone shows how patient testing and regulatory cooperation can bring new safety technologies to people who need them.